BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine
Titel:
BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine
Auteur:
Miller, Aubrey L. Fehling, Samuel C. Vance, Rebecca B. Chen, Dongquan Brown, Eric Josh Hossain, M. Iqbal Heard, Eric O. Andrabi, Shaida A. Wang, Hengbin Yang, Eddy S. Buchsbaum, Donald J. van Waardenburg, Robert C.A.M. Bellis, Susan L. Yoon, Karina J.